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Abstract 
Introduction: Candidiasis or oral candidiasis is the most frequent mucocutaneous mycosis of the oral cavity. It is 
produced by the genus Candida, which is found in the oral cavity of 53% of the general population as a common 
commensal organism. One hundred and fifty species have been isolated in the oral cavity, and 80% of the isolates 
correspond to Candida albicans, which can colonize the oral cavity alone or in combination with other species. 
Transformation from commensal organism to pathogen depends on the intervention of different predisposing fac-
tors that modify the microenvironment of the oral cavity and favor the appearance of opportunistic infection.
The present study offers a literature review on the diagnosis of oral candidiasis, with the purpose of establishing 
when complementary microbiological techniques for the diagnosis of oral candidiasis should be used, and which 
techniques are most commonly employed in routine clinical practice in order to establish a definitive diagnosis. 
Materials and methods: A Medline-PubMed, Scopus and Cochrane search was made covering the last 10 years.
Results: The diagnosis of oral candidiasis is fundamentally clinical. Microbiological techniques are used when 
the clinical diagnosis needs to be confirmed, for establishing a differential diagnosis with other diseases, and in 
cases characterized by resistance to antifungal drugs. Biopsies in turn are indicated in patients with hyperplastic 
candidiasis. Staining (10% KOH) and culture (Sabouraud dextrose agar) are the methods most commonly used 
for diagnosing primary candidiasis. Identification of the individual species of Candida is usually carried out with 
CHROMagar Candida®. For the diagnosis of invasive candidiasis, and in cases requiring differentiation between 
C. albicans and C. dubliniensis, use is made of immunological and genetic techniques such as ELISA and PCR.
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Introduction
Mycoses comprise a series of infectious diseases caused 
by the pathogenic action of fungi. Although most fungal 
species are present as saprophytes in the environment 
and in plants, where they play a key role in the natural 
recycling of organic material, some of them are able to 
cause disease in humans. Such conditions manifest as 
allergic processes caused by the inhalation of spores, in-
toxication as a result of the ingestion of harmful substan-
ces (mycetismus or mushroom poisoning and mycotoxi-
cosis), or infections, since some fungal species are able 
to colonize, invade and multiply in different body tissues 
and organs, causing mycosis in a previously healthy host 
(primary pathogenic fungi) or in individuals with dimi-
nished defense mechanisms (opportunistic fungi). The 
clinical profile of mycosis varies greatly depending on 
the causal agent, the location of the infection, and the 
predisposing factors of the patient. One of the most wi-
dely used practical classifications of mycoses is based 
on the location of the infection. In this sense, mycoses 
can be classified as superficial, cutaneous or mucocuta-
neous, subcutaneous, and deep or systemic. Mucocuta-
neous mycoses affect skin and mucosal membrane inte-
grity, and moreover produce inflammation.
Candidiasis or oral candidiasis, produced by fungi of 
the genus Candida (Candida spp.), is the most frequent 
mucocutaneous mycosis of the oral cavity. Candida is 
found in the oral cavity of 53% of the general population 
as a common commensal organism. One hundred and 
fifty species of this genus have been isolated in the oral 
cavity, and 80% of the isolates correspond to Candida 
albicans, which can colonize the cavity alone or in com-
bination Candida glabrata or Candida tropicalis (obser-
ved in 7% of all healthy people and in 80% of all patients 
with candidiasis). Recently, Candida dubliniensis has 
been isolated in patients with human immunodeficiency 
virus (HIV) infection. This species is important, since 
it is associated with very severe candidiasic mucositis 
of the oral cavity, esophagus and other locations, and is 
moreover resistant to antifungal treatment. Despite the 
above observations, the prevalence of oral candidiasis is 
not well known, since in many cases these processes go 
undetected by the clinician. Nevertheless, the diagnosis 
of the disease is very important, since it may be the first 
manifestation of a systemic disorder, including possible 
HIV infection (1). 
The pathogenesis of candidiasis combines three factors: 
host, fungus and oral microenvironment-modifying fac-
tors. The host predisposing factors include endocrine al-
terations (diabetes mellitus, pregnancy, renal failure and 
hyperthyroidism)(2,3), immune depression (normally 
associated to antineoplastic treatments or immunosu-
ppression in transplant patients, as well as agammaglo-
bulinemia or cellular immune defects)(1,4-8), acquired 
immunodeficiency syndrome (AIDS) or hematological 
and immune disorders such as agranulocytosis (neu-
tropenia). Other predisposing conditions are malignant 
diseases such as lymphomas or leukemias, aplastic ane-
mia, drug treatments (long-term administration of broad 
spectrum antibiotics, corticosteroids, antidepressants, 
antineoplastic drugs and immunosuppressants)(9-11), 
hyposialia (produced by disorders such as Sjögren’s di-
sease, drugs or radiotherapy), and terminal or end-stage 
systemic diseases (10,12,13). The oral microenviron-
ment-modifying factors in turn include poorly fitting 
dentures (14-17), loss of vertical dimension, chronic 
antiseptic use, prolonged dummy use in children, poor 
oral hygiene (16), smoking and alcoholism (10,18). The 
genus Candida is the most common of the many types 
of fungi found in the oral cavity. The species of Candida 
spp. isolated in the oral cavity are C. albicans, C. tro-
picalis, C. parapsilosis, C. krusei, C. guillermondii, C. 
glabrata and C. dubliniensis. Candida albicans posses-
ses pathogenicity factors that allow it to develop disea-
se more frequently than other species of Candida. The 
formation of germinal tubes and the presence of certain 
glycoproteins such as mannose and glucose in the fungal 
wall facilitate adherence to cell membranes and recep-
tors. At the same time, the presence of germinal tubes 
and the production of phospholipase C also facilitate fun-
gal invasion. Some components of these yeasts alter the 
host defense mechanisms (e.g., inhibiting phagocytosis). 
On the other hand, certain polysaccharides in the fun-
gal wall induce suppressor T lymphocytes, and mannan 
found in the wall can interfere with antigen presentation, 
inhibiting the immune defense response. Tissue damage 
results from direct action of the microorganism but also 
from the host defenses developed against tissue inva-
sion, including IgE-mediated immune allergic reactions 
against the fungal antigens and delayed hypersensitivi-
ty reactions – as in chronic mucocutaneous candidiasis. 
Thus, in order for Candida to produce infection, it must 
colonize, invade and multiply.
Candida is a rounded and oval-shaped yeast measuring 
3-30 µm in diameter. It reproduces asexually through a 
budding process in which protoplasmic protrusions or 
buds (blastoconidia) emerge from the mother cell and 
grow until they finally detach to form a new cell. The 
daughter cells occasionally do not detach and form 
chains of cells called pseudohyphae, which can be mis-
taken for hyphae. The latter are composed of a row of 
elongated cells enveloped by a cell wall; they globally 
conform the mycelium (septate and ramified hyphae). In 
solid culture media, the yeast grows, giving rise to com-
pact colonies that are macroscopically visible after 24-48 
hours of incubation. Candida must be in the saprophytic 
phase in order to produce clinical lesions, though over 
time nutritional and environmental variations modulate 
its conversion to the mycelial or invasive form. In this 
phase the yeast keeps its previous virulence intact, and is 
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ween primary oral candidiasis and secondary forms of 
the disease, in which oral candidiasis merely constituted 
one of the manifestations of mucocutaneous-systemic 
candidiasic infection. At present, the most widely used 
classification is that developed by Holmtup and Axel 
(2), which contemplates the following presentations: 
pseudomembranous candidiasis (acute-chronic), erythe-
matous candidiasis (acute-chronic), hyperplastic candi-
diasis, and associated lesions (prosthetic stomatitis, an-
gle cheilitis, rhomboid glossitis).
Pseudomembranous candidiasis is usually observed in 
immune depressed individuals, irradiated patients, nur-
sing infants (due to the low pH in the oral cavity and 
the lack of a stable microbial ecosystem capable of in-
hibiting development of the fungus), elderly people, and 
patients with xerostomia or diabetes mellitus. It tends to 
manifest in the form of whitish-yellow plaques (masses 
of hyphae, yeasts, cell detritus and desquamated epithe-
lial cells) of a soft and gelatinous consistency that ex-
hibit a centrifugal growth pattern. The lesions appear 
especially in the oropharyngeal region, cheek mucosa 
and lateral surfaces of the tongue. The whitish-yellow 
plaques detach upon rasping, leaving an erythematous 
zone. Symptoms are scarce (burning and itching sen-
sation). Dysphagia may be observed when the lesions 
affect the oropharynx (21,24).
Acute erythematous candidiasis is the most common pre-
sentation in both immune depressed and immunocompe-
tent individuals, and tends to manifest as a complication 
of broad spectrum antibiotic treatment. It is characterized 
by erythematous and atrophic regions located anywhere 
within the oral cavity, but particularly on the palate and 
tongue. The filiform papillae disappear, and the dorsal 
surface of the tongue appears smooth. The condition is 
usually asymptomatic or is accompanied by mild bur-
ning and itching sensation (12,18,22-24).
Chronic hyperplastic candidiasis can manifest in nodu-
lar form or as whitish plaques that cannot be attributed to 
any other disorder, do not detach upon rasping, and are 
typically located on the cheek mucosa and tongue, and 
especially bilaterally at both lip retro-commissures. In 
this form of the disease the Candida hyphae are not only 
found at epithelial surface level but also invade deeper 
levels where epithelial dysplasia can be observed – with 
the associated risk of malignization (18,25).
Prosthetic stomatitis manifests as erythematous zones 
closely related to the base of poorly fitting and very 
old removable dentures with poor hygiene that produ-
ce continuous trauma (14-22). A punctate (Newton 1) 
or extensive smooth reddened appearance can be ob-
served (Newton 2), or extensive reddening with hyper-
plastic growth can be noted (Newton 3)(2, 18, 26). The 
underlying etiology is multifactorial (dentures, hygiene 
and microbiological, dietetic and systemic factors), and 
infection due to Candida can be involved.
able to evade macrophage phagocytic action (19,26).
The diagnosis of any of the forms of oral candidiasis is 
essentially clinical and is based on recognition of the le-
sions, which can be confirmed by the microscopic iden-
tification of Candida in the oral samples and/or isolation 
in culture, among other diagnostic methods. In the case 
of Candida, detection of the fungus in the oral cavity is 
not indicative of infection, since it is a common com-
mensal organism in this location. A definitive diagnosis 
of candidiasis requires the confirmation of tissue inva-
sion by Candida. For this reason a negative culture result 
is of greater use in discarding candidiasic infection than 
a positive culture result in confirming infection. It may 
be stated that in the absence of clinical manifestations 
compatible with oral candidiasis, a positive culture re-
sult for Candida does not mean that the patient has oral 
candidiasis. The importance of the clinical diagnosis of 
the disease therefore must be underscored (2).
Objectives
The present study describes the correct clinical diagno-
sis of oral candidiasis, the situations in which comple-
mentary microbiological techniques for the diagnosis of 
oral candidiasis should be used, and the techniques most 
commonly employed in routine clinical practice to esta-
blish a definitive diagnosis.
Material and Methods
A literature search was made using the following key 
words: “clinical”, “microbiology” and “oral candidia-
sis”. The key words were validated by the MeSH (Medi-
cal Subject Headings) dictionary, with use of the boolean 
operator “AND” to relate them.
The following limits for inclusion of the studies were es-
tablished: publications in the last 10 years (2002-2012), 
publications in English and Spanish, publications of stu-
dies in humans, and all articles with level I and II evi-
dence (systematic reviews and clinical trials).
The search for articles was made with the Medline-Pub-
Med, Cochrane and Scopus databases, in that order.
Following application of the limits, two searches were 
made in each of the databases, using the following key 
words in English: “Clinical diagnosis AND oral can-
didiasis” and “Microbiology AND oral candidiasis”. A 
total of 183 articles were identified, of which 89 were 
selected after reading the abstracts. Following analysis 
of the 89 articles, we finally included a total of 37, since 
those publications that did not fit the aims of the present 
study were excluded. Of the mentioned 37 articles, 28 
were clinical trials and 9 systematic reviews.
Results and discussion
In the early twentieth century it was seen that oral candi-
diasis could have different clinical and histopathological 
manifestations. Posteriorly, a distinction was made bet-
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Angle cheilitis usually appears in patients with vitamin 
and iron deficiencies, or staphylococcal infections, as 
well as in totally or partially edentulous individuals with 
vertical dimension loss. The consequence is the forma-
tion of fissures or cracks at the lip commissures, with the 
accumulation of saliva that favors the generation of a 
humid environment and colonization by Candida. Over 
time, the fissures and erosions can produce crusts and 
pain. These patients typically present mixed infections, 
with the presence of bacteria such as Staphylococcus au-
reus or certain streptococci (10,18,27).
Median rhomboid glossitis (MRG) was first described 
by Brocq in 1914, and affects less than 1% of the general 
population. It is more commonly seen in males, smokers 
and diabetic patients. Clinically, MRG affects the poste-
rior region of the back of the tongue, on the midline an-
terior to the lingual “V”, and rarely the paramedial zone. 
The condition manifests as an asymptomatic, rounded 
or rhomboid plaque of firm consistency and an intense 
red or pink color, secondary to atrophy or the absence 
of filiform papillae, with limits that are clearly diffe-
rentiated from the rest of the tongue. There are two dis-
tinct clinical presentations: an atrophic or macular and 
non-elevated (flat) form, or a mamillated, hyperplastic 
or exophytic lesion that can appear elevated (up to 2-5 
mm). In some cases a fissured or lobulate lesion can be 
observed (10,18,28).
The diagnosis of any of the forms of oral candidiasis is 
essentially clinical and is based on recognition of the le-
sions, which can be confirmed by the microscopic iden-
tification of Candida in the oral samples and/or isolation 
in culture, among other diagnostic methods. In the case 
of Candida, detection of the fungus in the oral cavity is 
not indicative of infection, since it is a common com-
mensal organism in this location. A definitive diagnosis 
of candidiasis requires the confirmation of tissue inva-
sion by Candida. This underscores the importance of the 
clinical diagnosis of the disease (27).
A microbiological study is usually required when there 
are diagnostic doubts, resistances to antifungal drugs, or 
when the antifungal drug dose requires adjustment, as in 
immune depressed patients. Microbiological techniques 
are also typically used when it is necessary to control the 
disease with a view to avoiding distant spread of the in-
fection, and where the species of Candida must be iden-
tified in order to establish the most effective treatment. 
Biopsies are always required in hyperplastic candidiasis 
in order to discard the existence of epithelial dysplasia 
(29).
Identification of the yeasts can be made based on four 
different criteria: morphological and biochemical (for 
the diagnosis of oral candidiasis), or immunological and 
genetic (for the diagnosis of invasive candidiasis or the 
differentiation of species such as C. albicans and C. du-
bliniensis) (30,31). 
Although the clinical diagnosis of oral candidiasis is 
relatively simple, confirmation of the diagnosis can be 
made by the microscopic observation of Candida in oral 
lesion samples (microscopic morphological criteria) and 
by isolation in culture (macroscopic morphological crite-
ria) (Fig. 1). Microscopic examination can be made with 
fresh samples, using 10% potassium hydroxide (KOH), 
which dissolves the epithelial cells and leaves Candida 
intact, or 15-30% sodium hydroxide (NaOH)(29). It is 
also possible to prepare smears or imprints of the lesion 
samples, followed by conventional Giemsa or PAS stai-
ning, or rapid techniques such as gram staining. In the 
case of hyperplastic candidiasis, a biopsy of the lesions 
is usually obtained and stained with hematoxylin-eosin 
(showing the yeasts and pseudomycelia of Candida with 
a violet color), PAS or Gomori-Grocott methenamine 
silver (29-33). Macroscopic observation is made in cul-
ture plates. The culture medium used is Sabouraud dex-
trose agar (SDA), which allows selective fungal growth. 
Chloramphenicol 0.05 g/l or gentamycin 0.5 g/l is usua-
lly added to this medium in order to inhibit bacterial 
growth. It is also possible to add cycloheximide 0.05 g, 
since it prevents the overgrowth of other accompanying 
fungi (Fig. 1). Following incubation (24-48 hours), whi-
tish cottony colonies are observed (7,13,31,33).
Using cultures, we can isolate the genus Candida and 
identify the species. For the identification of C. albicans 
we use the early filamentation test or germ tube test. 
Cornstarch agar, Oxgall-Tween-Caffeic acid (TOC), di-
luted milk and different sera, such as horse serum, can 
be used for such tests. Horse serum is the most widely 
used option, with incubation at 37ºC during 2-3 hours 
(21). Following the incubation period we can observe 
the characteristic germ tubes of C. albicans. The identi-
fication of germ tubes and chlamydoconidia is indicative 
of infection produced by C. albicans and/or C. dubli-
niensis, while their absence is indicative of probable in-
fection due to non-C. albicans species (Fig. 1).
In this latter case, in which other species of Candida 
must be evaluated, we can use biochemical methods, 
including enzyme techniques, nutrient assimilation me-
thods and mixed techniques that combine enzymatic and 
nutrient assimilation tests. The enzyme techniques (chro-
mogenic media, commercial media for the rapid identi-
fication of C. albicans, and commercial methods for the 
rapid identification of C. glabrata) detect the activity of 
certain yeast enzymes through the specific hydrolysis of 
a chromogenic substrate in the presence of an enzyme 
indicator. Many enzyme techniques are commercially 
available (CHROMagar Candida®, Candida ID®, Can-
dida ID 2®, CHROMagar-PAL®, Brilliance® Candida 
Agar, Colorex®, Chromogen albicans®, Albicans ID2®, 
Candiselect®, Fluoroplate® and Agar SDCA-MUAG®)
(5,7,8,14,22). However, the most frequently used system 
is CHROMagar Candida®, where C. albicans grows for-
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ming smooth green colonies, C. tropicalis forms smooth 
blue colonies, and C. krusei forms rough pink colonies 
(3,8,9,26). Another widely used chromogenic method is 
Candida ID®, where C. albicans grows to form smooth 
blue colored colonies, C. tropicalis and C. guillermondii 
generate pink colonies, and the rest of the species appear 
as white colonies (22)(Fig. 1). Regarding the sensitivity 
and specificity of the chromogenic methods, CHROMa-
gar Candida® and Candida ID® are simple, easy to use, 
accessible and offer good sensitivity and specificity, sin-
ce they allow presumptive identification of most species 
of Candida (Table 1,2). As can be seen in Table 1 and 
Table 2, Sahand et al. (27) propose the use of CHRO-
Magar Candida® with Pal agar (CHROMagar-PAL®), 
since it allows easy differentiation between C. albicans 
and C. dubliniensis even in mixed cultures (C. tropica-
lis, C. krusei and/or C. glabrata) – reaching a sensitivity 
of 97% and a specificity of 100%, approximately.
Fig. 1. Diagnosis of oral candidiasis.
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Among the range of biochemical techniques, the nu-
trient assimilation tests evaluate fungal capacity to use 
different sugars as sole carbon source. Media are used 
containing all the elements essential for growth, except 
a carbon source. A certain sugar is subsequently added 
to the medium, and the capacity of the fungus to assimi-
late that sugar is evidenced by its growth in the cultu-
re medium. This technique yields what is known as an 
auxonogram. The latter can be obtained by conventional 
techniques, using commercial micromethods, or auto-
mated systems. Many techniques are currently available 
and facilitate the use of these tests – making them faster 
but also more expensive. The nutrient assimilation tests 
include Auxacolor®, Uni-Yeast-Tek®, API 20 C AUX®, 
Galeria ID32C® and VITEK 2ID®. Lastly, among the 
biochemical methods, a number of commercial techni-
ques combine enzymatic tests and nutrient assimilation 
techniques, such as Rapid Yeast Plus System® and Fon-
giscreen 4H® (Fig. 1).
The species C. dubliniensis produces germ tubes and 
chlamydoconidia in the same way as C. albicans. In order 
to distinguish between them we therefore need to apply 
immunological and genetic criteria (Fig. 1). Such criteria 
are also used for the diagnosis of invasive candidiasis. 
Immunological criteria are used in the case of patients 
with complicated clinical conditions (such as immune 
depressed individuals), when it proves difficult to obtain 
deep samples, or when there are long waiting intervals 
between cultures (18,28,31). The immunological techni-
ques include methods based on the detection of mannan 
/ anti-mannan (Platelia™ Candida Ab/Ac/Ak) (32), the 
detection of antimycelial antibodies (Candida albicans 
IFA IgG), the detection of other antibodies (Candida De-
tect™), and the detection of (1-3) β-D-glucan (Fungitec 
G, Wako, B-Gstar) (25). The immunological procedures 
likewise include latex particle agglutination tests, based 
on the use of specific monoclonal antibodies (Bichro-
latex albicans®, Krusei-color®, Bichro-Dubli®).
The genetic techniques offer high sensitivity and speci-
ficity, and allow identification of the pathogen without 
having to perform cultures. Furthermore, samples from 
patients receiving antifungal treatment can be used (19) 
(Table 1,2). However, these techniques are more expen-
sive, and are not available in most hospital centers. The 
molecular diagnosis is based on nucleic acid hybridi-
zation and amplification techniques (5,33,36-38). The 
DIAGNOSTIC TEST C. albicans C. dubliniensis C. glabrata C. krusei C. tropicalis
CHROMAGAR-PAL® 98.50% 98.50% NS 95.50% 96.50%
Immunochromatographic mem-
brane test (albi-dubli®) 96.60% 98.30% NS NS NS
Modified chromogenic agar 94% 94.40% NS NS 94.50%
Agar BIGGY® 87% NS 90.90% NS 97%
Candida ID® 96.37% 95.35% NS NS NS
Multiplex PCR 90.39% 93.57% 90.40% 90.35% 90.35%
CHROMagar Candida® 98.60% 98.50% 90. 5% 96.20% 96.65%
Brilliance Candida Agar® 90.60% 84.60% NS 95.20% 61.20%
Candida ID2® 89.70% 92.80% NS NS 96.40%
Vitek 2ID® 85.50% NS NS NS 48%
Candiselect® 91.55% 98.30% 33% NS NS
NS: not specified
Table 1. Sensitivity of the diagnostic tests.
DIAGNOSTIC TEST C. albicans C. dubliniensis C. glabrata C. krusei C. tropicalis
CHROMAGAR-PAL® 98.50% 98.50% NS 95.50% 96.50%
Immunochromatographic mem-
brane test (albi-dubli®) 100.00% 100.00% NS NS NS
Modified chromogenic agar 100% 100.00% NS NS 100.00%
Agar BIGGY® 76% NS NS 100% 95%
Candida ID® 100.00% 96.93% NS NS NS
Multiplex PCR 100.00% 100.00% 100.00% 100.00% 100.00%
CHROMagar Candida® 98.80% 98.50% 98.3% 96.20% 96.65%
Brilliance Candida Agar® 95.75% 91.50% NS 99.00% 98.00%
Candida ID2® 97.00% 96.60% NS NS 100.00%
Vitek 2ID® NS NS NS NS NS
Candiselect® 100.00% 100.00% NS NS NS
NS: not specified
Table 2. Specificity of the diagnostic tests.
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objective of the genetic systems is to identify yeasts 
directly in clinical samples without the need to extract 
nucleic acids – thereby eliminating the culture time and 
lowering the costs. Bosco-Borgeat et al. (39) and Liguo-
ri et al. (40) propose Multiplex polymerase chain reac-
tion (PCR) assays, since they meet the aforementioned 
objective; however, although these assays are valid, they 
remain expensive.
Conclusions
The diagnosis of oral candidiasis is fundamentally cli-
nical. A microbiological diagnosis is performed when 
the clinical diagnosis requires confirmation; for establis-
hing a differential diagnosis with other diseases; in ca-
ses characterized by resistance to antifungal drugs; and 
in hyperplastic candidiasis, where biopsies are made. 
The methods most frequently used for the diagnosis of 
primary candidiasis are smears, stains (10% KOH) and 
cultures (Sabouraud dextrose agar). In determining the 
species of Candida, the most widely used techniques are 
CHROMagar Candida® and Candida ID®, since they 
offer good sensitivity and specificity and are accessible 
and simple to use – allowing the presumptive identifica-
tion of most Candida species. When diagnosing invasi-
ve candidiasis, and in cases where a differentiation bet-
ween C. albicans and C. dubliniensis is required, use is 
made of immunological techniques such as ELISA and 
genetic methods such as PCR assay. Although a new me-
thod has been proposed, known as CHROMagar-PAL®, 
which combines CHROMagar Candida® and Pal agar 
and allows simple and easy differentiation between C. 
albicans and C. dubliniensis even in mixed cultures, 
Multiplex PCR is currently advised since it identifies 
yeasts directly in clinical samples without the need for 
nucleic acid extraction - thereby eliminating the culture 
time and lowering the costs, though the method is still 
expensive.
References
1. Bensadoun RJ, Patton LL, Lalla RV, Epstein JB. Oropharyngeal 
candidiasis in head and neck cancer patients treated with radiation: 
update 2011. Support Care Cancer. 2011;19:737-44.
2. Aguirre-Urízar JM. Oral Candidiasis. Rev Iberoam Micol. 
2002;19:17-21.
3. Dorko E, Baranová Z, Jenca A, Kizek P, Pilipcinec E, Tkáciková 
L. Diabetes mellitus and candidiases. Folia Microbiol (Praha). 2002; 
50: 255-61.
4. Davies AN, Brailsford SR, Beighton D, Shorthose K, Stevens VC. 
Oral candidosis in community-based patients with advanced cancer. J 
Pain Symptom Manage. 2008;35:508-14.
5. Delgado AC, de Jesus Pedro R, Aoki FH, Resende MR, Trabasso P, 
Colombo AL. Clinical and microbiological assessment of patients with 
a long-term diagnosis of human immunodeficiency virus infection and 
Candida oral colonization. Clin Microbiol Infect. 2009;15:364-71.
6. López-Pintor RM, Hernández G, de Arriba L, de Andrés A. Oral 
candidiasis in patients with renal transplants. Med Oral Patol Oral Cir 
Bucal. 2013: (Ahead of ptint-article in press).
7. Fernández-Feijoo J, Diz-Dios P, Otero-Cepeda XL, Limeres-Posse 
J, de la Fuente-Aquado J et al. Predictive value oral candidiasis as 
a marker of progression to AIDS. Med Oral Patol Oral Cir Bucal. 
2005;10:36-40;32-6.
8. González Gravina H, González de Moran E, Zambrano O, Lozano 
Chouro M, Rodríguez de Valero S et al. Oral candidiasis in children 
and adolescents with cáncer. Identification of Candida ssp. Med oral 
Patol Oral Cir Bucal. 2007;12:E419-23.
9. Rodrigues JA, Höfling JF, Tavares FC, Duarte KM, Gonçalves RB, 
Azevedo RA. Evaluation of biochemical and serological methods to 
identify and clustering yeast cells of oral Candida species by CHRO-
Magar test, SDS-PAGE and ELISA. Braz Oral Biol. 2004;64:317-26.
10. Farah CS, Lynch N, McCullough MJ. Oral fungal infections: an 
update for the general practitioner. Aust Dent J. 2010;55:48-54.
11. Gaitan Cepeda LA, Ceballos Salobreña A, López Ortega K, Arzate 
Mora N, Jiménez Soriano Y. Oral lesions and immune reconstitution 
syndrome in HIV/AIDS patients receiving highly active antiretroviral 
therapy. Epidemiological evidence. Med Oral Patol Oral Cir Bucal. 
2008.13:E85-93.
12. Margaix-Muñoz M, Bagán JV, Poveda R, Jiménez Y, Sarrión G. 
Sjögren syndrome of the oral cavity. Review and update. Med Oral 
Patol Oral Cir Bucal. 2009;14:E325-30.
13. Ergun S, Cekici A, Topcuoglu N, Migliari DA, Külekçi G et al. 
Oral status and Candida colonization in patients with Sjögren’s Syn-
drome. Med Oral Patol Oral Cir Bucal. 2010;15:e310-5.
14. Maver-Biscanin M, Mravak-Stipetic M, Jerolimov V. Effect of 
low-level laser therapy on Candida albicans growth in patients with 
denture stomatitis. Photomed Laser Surg. 2005;23:328-32
15. Perezous LF, Stevenson GC, Flaitz CM, Goldschmidt ME, Engel-
meier RL, Nichols CM. The effect of complete dentures with a metal 
palate on candida species growth in HIV-infected patients. J Pros-
thodont. 2006;15:306-15.
16. Coco BJ, Bagg J, Cross LJ, Jose A, Cross J, Ramage G. Mixed 
Candida albicans and Candida glabrata populations associated with 
the pathogenesis of denture stomatitis. Oral Microbiol Immunol. 
2008;23:377-83.
17. Uludamar A, Ozkan YK, Kadir T, Ceyhan I. In vivo efficacy of 
alkaline peroxide tablets and mouthwashes on Candida albicans in pa-
tients with denture stomatitis. 2010;18:291-6.
18. Lal S, Chussid S. Oral Candidiasis in pediatric HIV patients. N Y 
State Dent J. 2005;71:28-31.
19. Hermann PA, Berek ZSB, Nagy GC, Kamotsay KB, Rozgonyi FB. 
Pathogenesis, microbiological and clinical aspects of oral candidiasis. 
Acta Microbiologica et Immunologica Hungarica. 2001;48:479-95.
20. Domaneschi C, Massarente DB, de Freitas RS, de Sousa Marques 
HH, Paula CR, Migliari DA y cols. Oral colonization by Candida spe-
cies in AIDS pediatric patients. Oral Dis. 2011;17:393-8.
21. Moulias R. Clinical manifestations of candidosis in the older adult. 
Revue de Geriatrie. 2002;49:1741-2.
22. Gabler IG, Barbosa AC, Velela RR, Lyon S, Rosa CA. Incidence 
and anatomic localization of oral candidiasis in patients with AIDS 
hospitalized in a public hospital in Belo Horizonte, MG, Brazil. J Appl 
Oral Sci. 2008;16:247-50.
23. Terai Hab, Shimahara Mb. Usefulness of culture test and direct 
examination for the diagnosis of oral atrophic candidiasis. Internatio-
nal Journal of Dermatology. 2009;48:371-3.
24. Rautemaa RABCD, Ramage GE. Oral candidosis Clinical cha-
llenges of a biofilm disease. Critical Reviews in Microbiology. 
2011;37:328-36.
25. Dahlén G. Microbiological diagnostics in oral diseases. Acta 
Odontologica Scandinavica. 2006;64:164-8.
26. Gümrü B, Kadir T, Uygun-Can B, Ozbayrak S. Distribution and 
phospholipase activity of Candida species in different denture stomati-
tis types. Mycopathology. 2006;162:389-94.
27. Sahand IH, Maza JL, Eraso E, Montejo M, MD Moragues et al. 
Evaluation of CHROM-Pal medium for the isolation and direct iden-
tification of Candida dubliniensis in primary cultures from the oral 
cavity. J Med Microbiol. 2009;58:1437-42.
28. Oliveira MA, Carvalho LP, Gomes Mde S, Bacellar O, Barros TF, 
Carvalho EM. Microbiological and immunological features of oral 
candidiasis. 2007;51:713-9.
29. Mustafa Goregena, Ozkan Miloglub, Mustafa Cemil Buyukkurtc, 
Fatma Caglayanb, Ayse Esin Aktasd. Median Rhomboid Glossitis: A 
Clinical and Microbiological Study. European Journal of dentistry. 
2011;5:367-72.
30. Yang C, Gong W, Lu J, Zhu X, Qi Q. Antifungal drug susceptibili-
ty of oral Candida albicans isolates may be associated with apoptotic 
responses to Amphotericin B. 2010;39:182-7.
e286
J Clin Exp Dent. 2013;5(5):e279-86. Diagnosis of oral candidiasis
31. Chattopadhyay A, Gray LR, Patton LL, Caplan DJ, Slade GD, Tien 
HC y cols. Salivary secretory leukocyte protease inhibitor and oral 
candidiasis in human immunodeficiency virus type 1-infected persons. 
Infect Immun. 2004;72:1956-63.
32. Potón JJ, Moragues MD, Guindós G. Non-culture based diagnos-
tics. Candida and candidiasis. American society for Microbiology. Rev 
Iber Micol. 2002;24:181-6.
33. Liguori G, Di Onofrio V, Gallé F, Lucariello A, Albano L, Cata-
nia MR, Guida M. Candida albicans identification: comparison among 
nine phenotypic systems and a multiplex PCR. J Prev Med Hyg. 
2010;51:121-4.
34. Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shi-
moda T. Oral candidiasis associated with inhaled corticosteroid use: 
comparison of fluticasone and beclomethasone. 2003;90:646-51.
35. Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MA. Diffe-
rential invasion of Candida albicans isolates in an in vitro model of 
oral candidosis. Oral Microbiol Immunol. 2004;19:293-6.
36. Davies AN, Brailsford SR, Beighton D. Oral candidosis in patients 
with advanced cancer. Oral Oncology. 2006;42:698-702.
37. Green CB, Marretta SM, Cheng G, Faddoul FF, Ehrhart EJ, Hoyer 
LL. RT-PCR analysis of Candida albicans ALS gene expression in a 
hyposalivatory rat model of oral candidiasis and in HIV-positive hu-
man patients. Med Mycology. 2006;44:103-11.
38. Kanli A, Demirel F, Sezgin Y. Oral candidosis, denture cleanliness 
and hygiene habits in an elderly population. Anging Clin E.
39. Bosco-Borgeat ME, Taverna CG, Cordoba S, Isla MG, Murisengo 
OA et al. Prevalence of Candida dubliniensis fungemia in Argentina: 
identification by a novel multiplex PCR and comparison of different 
phenotypic methods. Mycopathologia. 2011;172:407-14.
40. Liguori G, Lucariello A, Colella G, De Luca A, P Marinelli. Rapid 
identification of Candida species in oral rinse solutions by PCR. J Clin 
Pathol. 2007;60:1035-9.
Conflict of interest
The authors declare that they have no conflict of interest.
